Publication | Closed Access

Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro

Metabolic SyndromeBiochemistryMedicinePhysiologyDiabetesSoybean Phenolic-rich ExtractsPhytochemicalDiabetes MellitusPharmacologyPolyphenolicsHealth Sciences